Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 12:04 PM
Ignite Modification Date:
2025-12-25 @ 11:58 AM
NCT ID:
NCT00410761
Group ID:
EG002
Title:
Open-Label Treatment Period: Vandetanib 300 mg/Vandetanib 300 mg
Description:
Participants who received vandetanib 300 mg during the blinded randomized treatment period and who were unblinded due to disease progression or as a result of protocol amendment 6 were given the option to continue to receive vandetanib 300 mg orally once daily in the open-label treatment period for as long as they still benefitted of it per investigator judgement or until they were given another anti-cancer therapy.
Deaths Number Affected:
52
Deaths Number At Risk:
None
Serious Number Affected:
53
Serious Number At Risk:
109
Other Number Affected:
32
Other Number At Risk:
109
Study:
NCT00410761
Results Section:
NCT00410761
Adverse Events Module:
NCT00410761